CDC Advisers Review Blood-Clotting Risk Associated With J&J’s Covid-19 Vaccine
U.S. vaccine advisers are meeting to consider whether to change recommendations on the use of Johnson & Johnson ’s Covid-19...
U.S. vaccine advisers are meeting to consider whether to change recommendations on the use of Johnson & Johnson ’s Covid-19...
Pfizer also said Tuesday that a final analysis of late-stage study results confirmed the drug, named Paxlovid, was 89% effective...
Molson Coors Beverage Co. learned some lessons after bringing corporate employees back to their offices in October. Color-coded wristbands can...
General Electric Co. , Union Pacific Corp. and other large employers have suspended Covid-19 vaccine requirements for workers after a...
Human blood samples and the substance that makes fireflies glow are among the tools that scientists are using for early...
Eli Lilly & Co.’s monoclonal antibody drug has been cleared for emergency use in children under the age of 12,...
A Covid-19 antibody treatment developed by GlaxoSmithKline PLC and Vir Biotechnology Inc. was effective against the Omicron variant in early...
A federal jury in Cleveland on Tuesday found that the companies owning CVS, Walgreens and Walmart pharmacies were liable for...
The Food and Drug Administration on Friday cleared Covid-19 boosters from Pfizer Inc. and BioNTech SE and from Moderna Inc....
Pfizer Inc. said it asked U.S. health regulators to authorize its oral Covid-19 drug for use in high-risk patients, putting...
Pfizer Inc. said a preliminary look at study results found that its experimental pill was highly effective at preventing people...
Pfizer Inc. raised its forecast for sales of its Covid-19 vaccine this year to about $36 billion, a roughly 7%...
Merck & Co. will license a promising Covid-19 drug to a United Nations-backed nonprofit to provide more supplies to low-...
A pair of new companies are being launched to tackle high drug costs, the latest sign of employer frustration with...
The Food and Drug Administration said the Covid-19 vaccine from Pfizer Inc. PFE 0.70% and BioNTech SE BNTX -2.80% met...
U.S. health regulators significantly widened the nation’s Covid-19 booster campaign, clearing use of extra doses of Moderna Inc. and Johnson...
Johnson & Johnson’s JNJ 2.55% sales climbed in the latest quarter compared with the same stretch of last year, reflecting...
The Food and Drug Administration is delaying a decision on authorizing Moderna Inc.’s MRNA -2.41% Covid-19 vaccine for adolescents to...
WASHINGTON—Supply-chain disruptions and global health concerns spurred the International Monetary Fund to lower its 2021 growth forecast for the world...
Johnson & Johnson’s JNJ -0.42% top scientist, who oversaw a turnaround in the company’s pharmaceutical unit and the development of...